125 related articles for article (PubMed ID: 7849232)
1. The influence of chronic lobular hepatitis on pharmacokinetics of cefoperazone--a novel galactose single-point method as a measure of residual liver function.
Hu OY; Tang HS; Chang CL
Biopharm Drug Dispos; 1994 Oct; 15(7):563-76. PubMed ID: 7849232
[TBL] [Abstract][Full Text] [Related]
2. Novel galactose single point method as a measure of residual liver function: example of cefoperazone kinetics in patients with liver cirrhosis.
Hu OY; Tang HS; Chang CL
J Clin Pharmacol; 1995 Mar; 35(3):250-8. PubMed ID: 7608313
[TBL] [Abstract][Full Text] [Related]
3. Assessment of liver function using a novel galactose single point method.
Tang HS; Hu OY
Digestion; 1992; 52(3-4):222-31. PubMed ID: 1334011
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of cefoperazone (2.0 g) and sulbactam (1.0 g) coadministered to subjects with normal renal function, patients with decreased renal function, and patients with end-stage renal disease on hemodialysis.
Reitberg DP; Marble DA; Schultz RW; Whall TJ; Schentag JJ
Antimicrob Agents Chemother; 1988 Apr; 32(4):503-9. PubMed ID: 3377461
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of promazine in patients with hepatic cirrhosis--correlation with a novel galactose single point method.
Hu OY; Tang HS; Sheeng TY; Chen TC; Curry SH
J Pharm Sci; 1995 Jan; 84(1):111-4. PubMed ID: 7714731
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacokinetic study of a cephalosporin, cefoperazone, in liver failure].
Belaieff J; Cochet B; Allaz AF; Rudhardt M; Balant L; Fabre J
Schweiz Med Wochenschr; 1981 Apr; 111(14):502-8. PubMed ID: 6453423
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of cefoperazone and sulbactam in liver transplant patients.
Muder RR; Agarwala S; Mirani A; Gayowski T; Venkataramanan R
J Clin Pharmacol; 2002 Jun; 42(6):644-50. PubMed ID: 12043952
[TBL] [Abstract][Full Text] [Related]
8. Cefoperazone pharmacokinetics in patients with liver cirrhosis: a predictive value of the ujoviridin test.
Saudek F; Morávek J; Modr Z
Int J Clin Pharmacol Ther Toxicol; 1989 Feb; 27(2):82-7. PubMed ID: 2921099
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of cefoperazone in patients with normal and impaired hepatic and renal function.
Greenfield RA; Gerber AU; Craig WA
Rev Infect Dis; 1983; 5 Suppl 1():S127-36. PubMed ID: 6221382
[TBL] [Abstract][Full Text] [Related]
10. [The prognostic value of the serial determination of galactose elimination capacity in chronic active hepatitis].
Aebli N; Reichen J
Schweiz Med Wochenschr; 1991 Jun; 121(26):970-6. PubMed ID: 1862313
[TBL] [Abstract][Full Text] [Related]
11. Comparative evaluation of the pharmacokinetics of N-methylthiotetrazole following administration of cefoperazone, cefotetan, and cefmetazole.
Welage LS; Borin MT; Wilton JH; Hejmanowski LG; Wels PB; Schentag JJ
Antimicrob Agents Chemother; 1990 Dec; 34(12):2369-74. PubMed ID: 2088192
[TBL] [Abstract][Full Text] [Related]
12. Multiple-dose pharmacokinetics and toleration of intravenously administered cefoperazone and sulbactam when given as single agents or in combination.
Reitberg DP; Whall TJ; Chung M; Blickens D; Swarz H; Arnold J
Antimicrob Agents Chemother; 1988 Jan; 32(1):42-6. PubMed ID: 3348612
[TBL] [Abstract][Full Text] [Related]
13. Penetration of cefoperazone into ascites.
Van Gossum A; Quenon M; Van Gossum M; Herchuelz A; Thys JP
Eur J Clin Pharmacol; 1989; 37(6):577-80. PubMed ID: 2612553
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of cefoperazone in horses.
Soraci AL; Mestorino ON; Errecalde JO
J Vet Pharmacol Ther; 1996 Feb; 19(1):39-43. PubMed ID: 8992024
[TBL] [Abstract][Full Text] [Related]
15. Effects of hyperglycemia on quantitative liver functions by the galactose load test in diabetic rats.
Young TH; Tang HS; Lee HS; Hsiong CH; Hu OY
Metabolism; 2007 Sep; 56(9):1265-9. PubMed ID: 17697871
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of cefoperazone: a review.
Craig WA; Gerber AU
Drugs; 1981; 22 Suppl 1():35-45. PubMed ID: 6456890
[TBL] [Abstract][Full Text] [Related]
17. Steady-state pharmacokinetics of cefoperazone and sulbactam in patients with acute appendicitis.
Danziger LH; Piscitelli SC; Occhipinti DJ; Resnick DJ; Rodvold KA
Ann Pharmacother; 1994 Jun; 28(6):703-7. PubMed ID: 7919553
[TBL] [Abstract][Full Text] [Related]
18. Peritoneal absorption of cefoperazone in rats.
Najjar TA
J Chemother; 1992 Feb; 4(1):23-6. PubMed ID: 1403065
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of cefaronide, ceftriaxone and cefoperazone in sheep.
Guerrini VH; Filippich LJ; Cao GR; English PB; Bourne DW
J Vet Pharmacol Ther; 1985 Jun; 8(2):120-7. PubMed ID: 4020943
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of cefoperazone in normal volunteers and subjects with renal insufficiency.
Bolton WK; Scheld WM; Spyker DA; Sande MA
Antimicrob Agents Chemother; 1981 May; 19(5):821-5. PubMed ID: 6457558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
